To eliminate cancer as a major health problem by funding cancer research, providing patient programs and support, promoting prevention and early detection, and advocating for evidence-based public policy.
Acs Development Company II Inc’s 2024 grantmaking was defined by a single $2,640,763 contribution to American Cancer Society Inc in Atlanta for a new market tax credit contribution. That award sits within a broader mission tied to cancer: funding research, supporting patients, promoting prevention and early detection, and backing evidence-based public policy. The foundation’s active program list shows that this mission is carried out through research training, investigator-initiated studies, translational work, and patient-facing support. Several programs point to a strong emphasis on workforce development, including post-baccalaureate fellows and undergraduate internships in cancer research. Other grants target clinical impact more directly, such as support for moving patient-focused research toward application and expanding prostate cancer clinical trials in community settings. The structure of the portfolio suggests a funder that uses grants to support both the research pipeline and practical mechanisms that can shape access to cancer care and evidence generation. The year on file is 2024, and all reported grants went to recipients in Georgia.
Cancer research appears across multiple active programs. Research Scholar Grants support investigator-initiated projects for independent investigators, including population-based studies and Cancer Control & Prevention Research Program work. The ACS Flatiron Health Real-World Data Impact Award is a one-year grant for ACS investigators using de-identified real-world data for health services, health policy, or public health research. Training and workforce development is another clear theme. The ACS CICRT — Post-Baccalaureate Fellows Program funds 2-year post-baccalaureate cancer research training programs, while the ACS CICRT — Internship Program supports 10-week summer internships for undergraduate students in cancer research plus yearlong career development and networking. The foundation also funds clinical translation. Mission Boost Grants are designed to move patient-focused research toward clinical impact through Stage I and Stage II support, and ACS IMPACT — Expanding Prostate Cancer Clinical Trials in the Community aims to build infrastructure in local oncology practices and hospitals to increase participation of Black men with prostate cancer in trials.
$2.6M
$8.9M
$182K
$588K
Most grants fall between $2.6M and $2.6M, with a median of $2.6M.
25th Percentile
$2.6M
Median
$2.6M
75th Percentile
$2.6M
DR KAREN E KNUDSEN PHD
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The only grant size reported in the recent grants list is $2,640,763, which matches the annual total, so the latest year appears to reflect one grant at that amount. The foundation is local in scope, and the recipient pattern is concentrated in Georgia, with 100% of grants to recipients in the HQ state. The active program list shows a mix of unsolicited and invitation-only opportunities: several research and training programs accept unsolicited applications, while others, including the IMPACT clinical trials initiative and the Flatiron Health data award, do not. The foundation appears to operate through institutional and research-grant programs rather than individual giving; it does not fund individuals and does not make program-related investments.
Grantmaking is tightly concentrated in Georgia. The 2024 recipient list includes American Cancer Society Inc in Atlanta, and the geography summary shows 100% of grants went to recipients in the HQ state. The broader recipient distribution is entirely U.S.-based, with no non-U.S. countries appearing in the data. The foundation’s active programs are listed as U.S.-oriented, including research grants, training programs, and community-based clinical trial infrastructure.
Its active programs cover cancer research, cancer prevention, early detection and screening, patient services and support, training and fellowships, and childhood cancer. The program list also includes investigator-initiated research, translational research, and community-based clinical trial infrastructure.
Yes. Two listed programs are built around training: the ACS CICRT — Post-Baccalaureate Fellows Program funds 2-year post-baccalaureate cancer research training, and the ACS CICRT — Internship Program supports 10-week summer internships for undergraduate students plus yearlong career development and networking.
Some programs are, and some are not. The data shows unsolicited applications are accepted for Research Scholar Grants, Mission Boost Grants, ACS CICRT — Post-Baccalaureate Fellows Program, ACS CICRT — Internship Program, and TheoryLab Collaborative Grant. The IMPACT prostate cancer clinical trials program and the Flatiron Health Real-World Data Impact Award do not accept unsolicited applications.
The reported grant-size distribution is a single value: p25 $2,640,763, median $2,640,763, and p75 $2,640,763. That matches the latest annual grant total shown in the data.
Its giving is local and concentrated in Georgia. The recipient country distribution is entirely U.S.-based, and 100% of grants went to recipients in the HQ state.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Current and upcoming funding from Acs Development Company Ii that your nonprofit may be able to apply for.
Who can apply: Awarded to institutions as block grants. The principal investigator should be an associate or full professor.
Deadline: June 1 annually.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| AMERICAN CANCER SOCIETY INC | ATLANTA, GA | $2,640,763 | 2024 | NEW MARKET TAX CREDIT CONTRIBUTION |
